Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Animal Blood Plasma and Derivatives Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Immunoglobulin
      • 1.3.3 Fibrinogen
      • 1.3.4 Serum Albumin
      • 1.3.5 Fetal Bovine Serum
      • 1.3.6 Thrombin
      • 1.3.7 New Born Calf Serum
    • 1.4 Market Segment by Application
      • 1.4.1 Global Animal Blood Plasma and Derivatives Market Share by Application (2019-2025)
      • 1.4.2 Food & Beverages
      • 1.4.3 Pharmaceuticals
      • 1.4.4 Cosmetics
      • 1.4.5 Feed
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Animal Blood Plasma and Derivatives Market Size
      • 2.1.1 Global Animal Blood Plasma and Derivatives Revenue 2014-2025
      • 2.1.2 Global Animal Blood Plasma and Derivatives Sales 2014-2025
    • 2.2 Animal Blood Plasma and Derivatives Growth Rate by Regions
      • 2.2.1 Global Animal Blood Plasma and Derivatives Sales by Regions 2014-2019
      • 2.2.2 Global Animal Blood Plasma and Derivatives Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Animal Blood Plasma and Derivatives Sales by Manufacturers
      • 3.1.1 Animal Blood Plasma and Derivatives Sales by Manufacturers 2014-2019
      • 3.1.2 Animal Blood Plasma and Derivatives Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Animal Blood Plasma and Derivatives Revenue by Manufacturers (2014-2019)
      • 3.2.2 Animal Blood Plasma and Derivatives Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Animal Blood Plasma and Derivatives Market Concentration Ratio (CR5 and HHI)
    • 3.3 Animal Blood Plasma and Derivatives Price by Manufacturers
    • 3.4 Key Manufacturers Animal Blood Plasma and Derivatives Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Animal Blood Plasma and Derivatives Market
    • 3.6 Key Manufacturers Animal Blood Plasma and Derivatives Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Immunoglobulin Sales and Revenue (2014-2019)
      • 4.1.2 Fibrinogen Sales and Revenue (2014-2019)
      • 4.1.3 Serum Albumin Sales and Revenue (2014-2019)
      • 4.1.4 Fetal Bovine Serum Sales and Revenue (2014-2019)
      • 4.1.5 Thrombin Sales and Revenue (2014-2019)
      • 4.1.6 New Born Calf Serum Sales and Revenue (2014-2019)
    • 4.2 Global Animal Blood Plasma and Derivatives Sales Market Share by Type
    • 4.3 Global Animal Blood Plasma and Derivatives Revenue Market Share by Type
    • 4.4 Animal Blood Plasma and Derivatives Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Animal Blood Plasma and Derivatives Sales by Application

    6 United States

    • 6.1 United States Animal Blood Plasma and Derivatives Breakdown Data by Company
    • 6.2 United States Animal Blood Plasma and Derivatives Breakdown Data by Type
    • 6.3 United States Animal Blood Plasma and Derivatives Breakdown Data by Application

    7 European Union

    • 7.1 European Union Animal Blood Plasma and Derivatives Breakdown Data by Company
    • 7.2 European Union Animal Blood Plasma and Derivatives Breakdown Data by Type
    • 7.3 European Union Animal Blood Plasma and Derivatives Breakdown Data by Application

    8 China

    • 8.1 China Animal Blood Plasma and Derivatives Breakdown Data by Company
    • 8.2 China Animal Blood Plasma and Derivatives Breakdown Data by Type
    • 8.3 China Animal Blood Plasma and Derivatives Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Animal Blood Plasma and Derivatives Breakdown Data by Company
    • 9.2 Rest of World Animal Blood Plasma and Derivatives Breakdown Data by Type
    • 9.3 Rest of World Animal Blood Plasma and Derivatives Breakdown Data by Application
    • 9.4 Rest of World Animal Blood Plasma and Derivatives Breakdown Data by Countries
      • 9.4.1 Rest of World Animal Blood Plasma and Derivatives Sales by Countries
      • 9.4.2 Rest of World Animal Blood Plasma and Derivatives Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Proliant Inc.
      • 10.1.1 Proliant Inc. Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Animal Blood Plasma and Derivatives
      • 10.1.4 Animal Blood Plasma and Derivatives Product Introduction
      • 10.1.5 Proliant Inc. Recent Development
    • 10.2 Thermo Fisher Scientific, Inc.
      • 10.2.1 Thermo Fisher Scientific, Inc. Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Animal Blood Plasma and Derivatives
      • 10.2.4 Animal Blood Plasma and Derivatives Product Introduction
      • 10.2.5 Thermo Fisher Scientific, Inc. Recent Development
    • 10.3 Merck KGaA
      • 10.3.1 Merck KGaA Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Animal Blood Plasma and Derivatives
      • 10.3.4 Animal Blood Plasma and Derivatives Product Introduction
      • 10.3.5 Merck KGaA Recent Development
    • 10.4 Kraeber & Co GmbH
      • 10.4.1 Kraeber & Co GmbH Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Animal Blood Plasma and Derivatives
      • 10.4.4 Animal Blood Plasma and Derivatives Product Introduction
      • 10.4.5 Kraeber & Co GmbH Recent Development
    • 10.5 LAMPIRE Biological Laboratories, Inc.
      • 10.5.1 LAMPIRE Biological Laboratories, Inc. Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Animal Blood Plasma and Derivatives
      • 10.5.4 Animal Blood Plasma and Derivatives Product Introduction
      • 10.5.5 LAMPIRE Biological Laboratories, Inc. Recent Development
    • 10.6 Lake Immunogenics, Inc.
      • 10.6.1 Lake Immunogenics, Inc. Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Animal Blood Plasma and Derivatives
      • 10.6.4 Animal Blood Plasma and Derivatives Product Introduction
      • 10.6.5 Lake Immunogenics, Inc. Recent Development
    • 10.7 Rocky Mountain Biologicals Inc.
      • 10.7.1 Rocky Mountain Biologicals Inc. Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Animal Blood Plasma and Derivatives
      • 10.7.4 Animal Blood Plasma and Derivatives Product Introduction
      • 10.7.5 Rocky Mountain Biologicals Inc. Recent Development
    • 10.8 ANZCO Foods Ltd.
      • 10.8.1 ANZCO Foods Ltd. Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Animal Blood Plasma and Derivatives
      • 10.8.4 Animal Blood Plasma and Derivatives Product Introduction
      • 10.8.5 ANZCO Foods Ltd. Recent Development
    • 10.9 Auckland BioSciences Ltd.
      • 10.9.1 Auckland BioSciences Ltd. Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Animal Blood Plasma and Derivatives
      • 10.9.4 Animal Blood Plasma and Derivatives Product Introduction
      • 10.9.5 Auckland BioSciences Ltd. Recent Development
    • 10.10 Bovogen Biologicals Pty Ltd.
      • 10.10.1 Bovogen Biologicals Pty Ltd. Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Animal Blood Plasma and Derivatives
      • 10.10.4 Animal Blood Plasma and Derivatives Product Introduction
      • 10.10.5 Bovogen Biologicals Pty Ltd. Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Animal Blood Plasma and Derivatives Sales Channels
      • 11.2.2 Animal Blood Plasma and Derivatives Distributors
    • 11.3 Animal Blood Plasma and Derivatives Customers

    12 Market Forecast

    • 12.1 Global Animal Blood Plasma and Derivatives Sales and Revenue Forecast 2019-2025
    • 12.2 Global Animal Blood Plasma and Derivatives Sales Forecast by Type
    • 12.3 Global Animal Blood Plasma and Derivatives Sales Forecast by Application
    • 12.4 Animal Blood Plasma and Derivatives Forecast by Regions
      • 12.4.1 Global Animal Blood Plasma and Derivatives Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Animal Blood Plasma and Derivatives Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Animal Blood Plasma and Derivatives is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Animal Blood Plasma and Derivatives.

      This report studies the global market size of Animal Blood Plasma and Derivatives, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Animal Blood Plasma and Derivatives sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Proliant Inc.
      Thermo Fisher Scientific, Inc.
      Merck KGaA
      Kraeber & Co GmbH
      LAMPIRE Biological Laboratories, Inc.
      Lake Immunogenics, Inc.
      Rocky Mountain Biologicals Inc.
      ANZCO Foods Ltd.
      Auckland BioSciences Ltd.
      Bovogen Biologicals Pty Ltd.

      Market Segment by Product Type
      Immunoglobulin
      Fibrinogen
      Serum Albumin
      Fetal Bovine Serum
      Thrombin
      New Born Calf Serum

      Market Segment by Application
      Food & Beverages
      Pharmaceuticals
      Cosmetics
      Feed
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Animal Blood Plasma and Derivatives status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Animal Blood Plasma and Derivatives manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Animal Blood Plasma and Derivatives are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now